VISUfarma SpA   Report issue

For profit Phase 1 Phase 4
Founded: Amsterdam Netherlands (2016)
Status: No NME R&D (2016)

Organization Overview

First Clinical Trial
2018
NCT03819491
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

VISUfarma SpA

Active Ingredients

Drugs in Phase 4 Trials (1)

ubiquinone (2 trials)

Drugs in Phase 1 Trials (1)

vitamin e (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2